Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1476.2000 -35.00 (-2.32%)

NSE Mar 26, 2025 15:31 PM

Volume: 1.4M

Cipla Ltd.

30 Oct 2024

1476.20

-2.32%

Cipla (SELL): No meaningful incremental triggers until Goa plant clearance

Sell: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Earnings in line with our estimates on all fronts. However, US sales was down and 5% lower than our estimates in rupee terms

Number of FII/FPI investors decreased from 1132 to 1077 in Dec 2024 qtr